A Danish research team from the University of Copenhagen has designed a simple technique that makes it possible to quickly and easily develop a new type of vaccines. The simple and effective technique will pave the way for effective vaccines against not only infectious diseases but also cancer and other chronic diseases.
The next generation of vaccines may soon see the light of day, because Danish researchers have discovered a completely new and simple method which sets new standards for the development of vaccines.
“The major research breakthrough is that we have created a general and user-friendly platform for the development of a special type of effective and safe vaccines. The highly effective method opens a new door for controlling diseases such as cancer, asthma, allergies and cardiovascular diseases by means of vaccines. We are therefore already now able to initiate strategies to combat some of the biggest killers in the western world,” says Postdoc Adam Sander, Department of Immunology and Microbiology, University of Copenhagen.
How the new vaccines work
The idea behind the new technique is to mimic the structure of a virus. When you have made the virus structure, it is used as a platform onto which are glued harmless parts of the disease which you want to vaccinate against. This creates an overall virus-like structure, which constitutes an important danger signal for the body. The immune system will therefore produce antibodies against the disease – a mechanism which has been difficult to activate by traditional vaccines. The Danish research team’s technology is also so effective that it can trick the immune system into attacking the body’s own cells, which may be used in the treatment of a number of serious diseases, e.g. cancer, which are not caused by foreign organisms.
“We can see from our experiments that the method works. The method is generic, which means that we can glue, for example, different parts of pathogenic organisms onto the surface of the virus-like platform. Previously, it was a major problem to activate the immune system and get an adequate response. We have lacked the possibility to easily create a vaccine which mimics something that will trigger a natural response from the body, but the new virus-like platform now allows us to do so. In other words, we now have a unique technique that enables us to develop vaccines against diseases that we have so far been unable to fight,” says PhD student Susan Thrane.
The vaccine breakthrough also means that previous research in vaccines can get a new life. For many years, researchers have tried to find vaccines against, for example, malaria, cancer and allergies, but the vaccines have either been too ineffective or dangerous. However, the new research provides the ‘structural’ building blocks that were needed to make the vaccines effective. This means that new vaccine research can proceed directly to the development and testing of new vaccines against, for example, breast cancer and allergies.
Huge potential for development of inexpensive vaccines in low-income countries
The technique for the development of the new type of vaccines is very simple. Where vaccines have so far been complicated to develop and produce, it will now be possible for laboratories all over the world to employ and implement the technique.
“It has always been an important mission for us to make the platform available for researchers all over the world. With our research, we offer a very simple tool that allows health professionals to produce complex vaccines in an effective, safe and cost-effective manner. It will be a game changer for low-income countries, which can now make vaccines targeted at widespread diseases such as tuberculosis and malaria. There is no doubt that the new results will have a significant impact on tomorrow’s vaccines and public health,” says Professor Ali Salanti.
Learn more:Â Danish researchers behind vaccine breakthrough
The Latest on: Vaccines
[google_news title=”” keyword=”vaccines” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Vaccines
- AstraZeneca begins global COVID-19 vaccine draw due to surplus updated vaccineson May 8, 2024 at 1:44 am
In a significant move announced on Tuesday, AstraZeneca disclosed its decision to commence the withdrawal of its COVID-19 vaccine from distribution a ...
- FLiRT COVID-19 Variant Spreading Rapidly In US: Can Existing COVID-19 Vaccines Protect You From This New Coronavirus?on May 8, 2024 at 12:20 am
FLiRT, a group of new Covid-19 variants belonging to Omicron's JN.1 lineage, is spreading fast in the US, raising concern about a new wave of infections in summer.
- The Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide - because there is now a "surplus of available updated vaccines"on May 8, 2024 at 12:14 am
AstraZeneca has been moving into respiratory virus vaccines and obesity drugs as demand has slowed for covid vaccines. It's previously admitted in court documents the vaccine causes extremely rare ...
- AstraZeneca withdraws Covid-19 vaccine worldwide, citing surplus of newer vaccineson May 7, 2024 at 6:18 pm
Pharmaceutical company says newer shots led to decline in demand for AstraZeneca vaccine, which is no longer being manufactured or supplied ...
- Georgia health department provides free vaccines for uninsured and underinsured adultson May 7, 2024 at 5:34 pm
If you're still looking to get vaccinated, you're in luck.The federal government gave the Georgia Health Department a grant that they are using to get adults v ...
- How mRNA vaccines could be personalized cancer cureson May 7, 2024 at 2:30 am
An expanding pipeline of vaccines is giving patients new hope against some of the deadliest cancers, by training the body's immune system to attack malignancies. Why it matters: This personalized ...
- Ohio board reinstates license of doctor who made controversial claims about COVID vaccineson May 6, 2024 at 2:50 pm
Sherri Tenpenny's license has been reinstated by the Ohio State Medical Board, which governs medical professionals.
- Personalized mRNA vaccines: A new approach in melanoma treatmenton May 4, 2024 at 7:50 am
A personalized mRNA vaccine to treat melanoma has now reached late-stage trials in the UK. This is just the latest step in improving the cure rate of cancer.
- The Side Effects of Covid Vaccineson May 3, 2024 at 3:39 am
The Times has just published an article about Americans who believe they suffered serious side effects from a Covid vaccine. More than 13,000 of them have filed vaccine-injury claims with the federal ...
- Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?on May 3, 2024 at 2:00 am
All vaccines have at least occasional side effects. But people who say they were injured by Covid vaccines believe their cases have been ignored.
via Bing News